A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS)

Completed · Phase 2

Conditions studied: Open-Angle Glaucoma, Ocular Hypertension

In brief

The study objective is to compare IOP and safety outcomes based on plug placement (upper or lower puncta).

Key facts

Study ID

NCT00821002

Run by

Mati Therapeutics Inc.

People needed

32

Starts

2009-01-01

Expected to finish

2009-11-01

Last updated by the study team

2013-09-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Over 18 years
• Diagnosed with bilateral Open-Angle Glaucoma or Ocular Hypertension

You may not qualify if…

• Uncontrolled medical conditions
• Subjects who wear contact lenses
• Subjects requiring chronic topical artificial tears, lubricants, and /or requiring any other chronic topical medications

Where it is running

• Study site — Menlo Park, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.